Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1
Authors
Keywords
-
Journal
DARU-Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s40199-023-00482-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
- (2023) Siyu Gu et al. Experimental Hematology & Oncology
- Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
- (2023) Emine Bayraktar et al. Non-Coding RNA
- IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway
- (2022) Dong Liu et al. CELLULAR SIGNALLING
- The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
- (2022) Hengyou Weng et al. CANCER CELL
- Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
- (2021) Kuo-Hao Ho et al. BMC Medicine
- The comprehensive landscape of miR-34a in cancer research
- (2021) Sijing Li et al. CANCER AND METASTASIS REVIEWS
- Glycolysis
- (2021) Navdeep S. Chandel Cold Spring Harbor Perspectives in Biology
- Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function
- (2021) Zhanhu Mi et al. Journal of Orthopaedic Surgery and Research
- Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia
- (2021) Xinglin Liang et al. ONCOLOGY REPORTS
- LncRNA NR-104098 Inhibits AML Proliferation and Induces Differentiation Through Repressing EZH2 Transcription by Interacting With E2F1
- (2020) Yubin Feng et al. Frontiers in Cell and Developmental Biology
- Long Non-Coding RNA Taurine Upregulated Gene 1 Targets miR-185 to Regulate Cell Proliferation and Glycolysis in Acute Myeloid Leukemia Cells in vitro
- (2020) Weide Zhang et al. OncoTargets and Therapy
- Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia
- (2020) Yaqi Cheng et al. Genes
- miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation
- (2020) Xiao-Ping Xu et al. ACTA HISTOCHEMICA
- lncARSR sponges miR‐34a‐5p to promote colorectal cancer invasion and metastasis via hexokinase‐1‐mediated glycolysis
- (2020) Shuai Li et al. CANCER SCIENCE
- Low-Intensity Pulsed Ultrasound Modulates RhoA/ROCK Signaling of Rat Mandibular Bone Marrow Mesenchymal Stem Cells to Rescue Their Damaged Cytoskeletal Organization and Cell Biological Function Induced by Radiation
- (2020) Rong Zhang et al. Stem Cells International
- Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway
- (2020) Liman Lin et al. Frontiers in Pharmacology
- Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
- (2019) Luxi Wang et al. Molecular Neurodegeneration
- Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis
- (2019) Chong Chen et al. ONCOGENE
- Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop
- (2019) Fei Ma et al. CANCER LETTERS
- Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
- (2019) Mark A. Gregory et al. CLINICAL CANCER RESEARCH
- GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization
- (2019) Zhixin Li et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
- (2019) Yunhao Chen et al. Molecular Cancer
- LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a
- (2019) Cheng-Hong Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
- (2019) Yun Wang et al. Molecular Cancer
- Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia
- (2019) Andrew E. Shouksmith et al. ACS Medicinal Chemistry Letters
- miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7
- (2016) Yi Xiao et al. Oncology Letters
- Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia
- (2016) KUI SONG et al. Oncology Letters
- Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
- (2015) A M Dorrance et al. LEUKEMIA
- The role of miR-29 family members in malignant hematopoiesis
- (2014) Sona Kollinerova et al. BIOMEDICAL PAPERS-OLOMOUC
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
- (2014) Xiao-Li Ping et al. CELL RESEARCH
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells
- (2012) Ke Gong et al. BIOCHEMICAL JOURNAL
- The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome
- (2010) Patries M. Herst et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started